These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 27183619)
1. Distinct Mechanisms Underlie Boosted Polysaccharide-Specific IgG Responses Following Secondary Challenge with Intact Gram-Negative versus Gram-Positive Extracellular Bacteria. Kar S; Arjunaraja S; Akkoyunlu M; Pier GB; Snapper CM J Immunol; 2016 Jun; 196(11):4614-21. PubMed ID: 27183619 [TBL] [Abstract][Full Text] [Related]
2. Structurally identical capsular polysaccharide expressed by intact group B streptococcus versus Streptococcus pneumoniae elicits distinct murine polysaccharide-specific IgG responses in vivo. Arjunaraja S; Paoletti LC; Snapper CM J Immunol; 2012 Jun; 188(11):5238-46. PubMed ID: 22523389 [TBL] [Abstract][Full Text] [Related]
3. The nature of an in vivo anti-capsular polysaccharide response is markedly influenced by the composition and/or architecture of the bacterial subcapsular domain. Arjunaraja S; Massari P; Wetzler LM; Lees A; Colino J; Snapper CM J Immunol; 2012 Jan; 188(2):569-77. PubMed ID: 22156342 [TBL] [Abstract][Full Text] [Related]
4. Meningococcal serogroup C immunogenicity, antibody persistence and memory B-cells induced by the monovalent meningococcal serogroup C versus quadrivalent meningococcal serogroup ACWY conjugate booster vaccine: A randomized controlled trial. van Ravenhorst MB; van der Klis FRM; van Rooijen DM; Knol MJ; Stoof SP; Sanders EAM; Berbers GAM Vaccine; 2017 Aug; 35(36):4745-4752. PubMed ID: 28668575 [TBL] [Abstract][Full Text] [Related]
5. Different Dynamics for IgG and IgA Memory B Cells in Adolescents following a Meningococcal Serogroup C Tetanus Toxoid Conjugate Booster Vaccination Nine Years after Priming: A Role for Priming Age? Stoof SP; Buisman AM; van Rooijen DM; Boonacker R; van der Klis FR; Sanders EA; Berbers GA PLoS One; 2015; 10(10):e0138665. PubMed ID: 26458006 [TBL] [Abstract][Full Text] [Related]
6. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom. Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971 [TBL] [Abstract][Full Text] [Related]
7. Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancy. Pace D; Khatami A; Attard-Montalto S; Voysey M; Finn A; Faust SN; Heath PT; Borrow R; Snape MD; Pollard AJ Vaccine; 2016 Dec; 34(50):6350-6357. PubMed ID: 28029540 [TBL] [Abstract][Full Text] [Related]
8. Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool. Stoof SP; van der Klis FR; van Rooijen DM; Bogaert D; Trzciński K; Sanders EA; Berbers GA Vaccine; 2015 Jul; 33(32):3933-9. PubMed ID: 26100925 [TBL] [Abstract][Full Text] [Related]
9. Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells. Brynjolfsson SF; Henneken M; Bjarnarson SP; Mori E; Del Giudice G; Jonsdottir I J Infect Dis; 2012 Feb; 205(3):422-30. PubMed ID: 22158565 [TBL] [Abstract][Full Text] [Related]
10. Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate. Shen X; Lagergård T; Yang Y; Lindblad M; Fredriksson M; Wallerström G; Holmgren J Vaccine; 2001 May; 19(25-26):3360-8. PubMed ID: 11348699 [TBL] [Abstract][Full Text] [Related]
11. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels. Sen G; Chen Q; Snapper CM Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 months of age. Tejedor JC; Moro M; Merino JM; Gómez-Campderá JA; García-del-Rio M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Ruiz-Contreras J; Martin-Ancel A; Roca J; Boceta R; García-Corbeira P; Maechler G; Boutriau D; Pediatr Infect Dis J; 2008 Jul; 27(7):579-88. PubMed ID: 18536619 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help. Khan AQ; Lees A; Snapper CM J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364 [TBL] [Abstract][Full Text] [Related]
14. Persistence of serum bactericidal antibody one year after a booster dose of either a glycoconjugate or a plain polysaccharide vaccine against serogroup C Neisseria meningitidis given to adolescents previously immunized with a glycoconjugate vaccine. de Whalley PC; Snape MD; Kelly DF; Banner C; Lewis S; Diggle L; John TM; Yu LM; Omar O; Borkowski A; Pollard AJ Pediatr Infect Dis J; 2011 Nov; 30(11):e203-8. PubMed ID: 21673612 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of De-O-acetylated meningococcal C polysaccharide-tetanus toxoid conjugate vaccine in infancy: reactogenicity, immunogenicity, immunologic priming, and bactericidal activity against O-acetylated and De-O-acetylated serogroup C strains. Richmond P; Borrow R; Findlow J; Martin S; Thornton C; Cartwright K; Miller E Infect Immun; 2001 Apr; 69(4):2378-82. PubMed ID: 11254596 [TBL] [Abstract][Full Text] [Related]
16. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine. Rubinstein LJ; García-Ojeda PA; Michon F; Jennings HJ; Stein KE Infect Immun; 1998 Nov; 66(11):5450-6. PubMed ID: 9784556 [TBL] [Abstract][Full Text] [Related]
17. B cell memory to a serogroup C meningococcal conjugate vaccine in childhood and response to booster: little association with serum IgG antibody. Perrett KP; Jin C; Clutterbuck E; John TM; Winter AP; Kibwana E; Yu LM; Curtis N; Pollard AJ J Immunol; 2012 Sep; 189(5):2673-81. PubMed ID: 22855707 [TBL] [Abstract][Full Text] [Related]
18. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. Tejedor JC; Merino JM; Moro M; Navarro ML; Espín J; Omeñaca F; García-Sicilia J; Moreno-Pérez D; Ruiz-Contreras J; Centeno F; Barrio F; Cabanillas L; Muro M; Esporrin C; De Torres MJ; Caubet M; Boutriau D; Miller JM; Mesaros N Pediatr Infect Dis J; 2012 Oct; 31(10):1074-7. PubMed ID: 22828645 [TBL] [Abstract][Full Text] [Related]
19. Differential regulation of polysaccharide-specific antibody responses to isolated polysaccharides, conjugate vaccines, and intact Gram-positive versus Gram-negative extracellular bacteria. Snapper CM Vaccine; 2016 Jun; 34(30):3542-8. PubMed ID: 27133879 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and immunological properties of conjugates composed of group B streptococcus type III capsular polysaccharide covalently bound to tetanus toxoid. Lagergard T; Shiloach J; Robbins JB; Schneerson R Infect Immun; 1990 Mar; 58(3):687-94. PubMed ID: 2407652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]